Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like 83% of Gen Z say they’re job hoppers. Here’s how to handle old workplace retirement funds LVMH boss Bernard Arnault under investigation in Paris over Russian oligarch transactions A recession is coming and investors should be defensive, TCW CEO says Today’s graduates make almost $10,000 less than their parents, after adjusting for inflation Stocks making the biggest moves before the bell: Nike, Blue Apron, Bumble and more